Related Experiment Video
Updated: Apr 25, 2026
10:20
Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
7.9K
[CTIP2, a multifunctional protein: cellular physiopathology and therapeutic implications]
Valentin Le Douce1, Thomas Cherrier2, Raphaël Riclet3
1Institut de parasitologie et de pathologie tropicale, EA7292, université de Strasbourg, Strasbourg, France - IUT de Schiltigheim, 1 allée d'Athènes, Schiltigheim, France.
Medecine Sciences : M/S
|September 2, 2014
Summary
The transcription factor CTIP2 (BCL11B) is crucial for cell processes and epigenetic regulation. Understanding its role in diseases like cancer and HIV could lead to new therapeutic strategies.
Area of Science:
- Molecular Biology
- Epigenetics
- Cellular Physiology
Context:
- The transcription factor CTIP2 (BCL11B) plays a multifaceted role in cellular functions.
- Its mechanisms involve epigenetic gene regulation and control of the P-TEFb elongation factor.
Purpose:
- To explore the diverse functions of CTIP2 (BCL11B) in cellular physiology.
- To investigate the implications of CTIP2 deregulation in various pathologies.
- To identify CTIP2 as a potential therapeutic target.
Summary:
- CTIP2 (BCL11B) is a key transcription factor regulating gene expression through epigenetic mechanisms and P-TEFb.
- Deregulation of CTIP2 is linked to serious conditions such as cancer and cardiac hypertrophy.
- CTIP2 and associated proteins are potential targets for managing HIV-1 reservoirs.
Impact:
- Elucidating CTIP2's role can advance understanding of cancer and cardiac hypertrophy.
- Targeting CTIP2 may offer novel therapeutic avenues for these diseases.
- CTIP2 presents a promising target for reducing and purging HIV-1 cell reservoirs.
Related Concept Videos
01:19Allosteric Proteins-ATCase
4.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
4.8K
01:26Cellular Adaptation II: Hypertrophy
37
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...
37
01:29Tight Junctions
6.8K
Tight junctions are molecular seals between cells that prevent the leaking of fluids, ions, and other small solutes across cavities and compartments in multicellular organisms. They are mainly composed of claudin and occludin transmembrane proteins, and other proteins such as tricellulin and JAM (junctional adhesion molecule). All these proteins are 4-pass transmembrane proteins, except JAM, which is a single-pass transmembrane protein belonging to the immunoglobulin superfamily. The...
6.8K